Sign in
Not yet recruitingNo phase

Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes

Key facts

Who runs it
SkylineDx
Trial code
Status
Not yet recruiting
People taking part
2,000 people, planned
Starts
Jan 2027
Expected to end
Jan 2032
Type of study
Observational
Record updated
13 November 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Newly diagnosed invasive malignant melanoma of the skin (AJCC 8th edition staging guidelines)
  • pT1-pT4 cN0M0
  • Male or female, age ≥65 years
  • Merlin CP-GEP testing performed, and a valid result obtained
  • Ability to provide informed consent, or availability of a legally authorized representative when permitted by applicable law and institutional policy

Who cannot take part

  • Documented history of another (prior or concurrent) primary invasive melanoma of T1a or greater at any site in their lifetime
  • Previous surgery or radiation therapy to the draining lymph node basin(s) of the current primary melanoma
  • Distant metastatic disease (M1a, M1b, M1c, or M1d) clinically present at primary diagnosis
  • Ocular, vulvar, perianal, or mucosal melanomas, or melanocytic tumors of uncertain malignant potential (MELTUMP) or atypical Spitz tumors
  • Documented clinically apparent nodal metastases at diagnosis

About the trial

What the trial wants to find out

The purpose of the registry is to understand how Merlin CP-GEP testing is used in routine care and whether the test result is associated with clinical decision-making in people with melanoma who are 65 years of age or older. The study will also collect available information about treatment decisions and clinical outcomes over time.

The group in the trial

  • Newly diagnosed primary cutaneous melanoma patients

    Newly diagnosed primary cutaneous melanoma patients, 65 years of age and older, with a valid Merlin CP-GEP result.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Merlin CP-GEP Prospective Clinical Registry
Record updated
13 November 2026